RediClinic's Kersey named as partner at Camden

BALTIMORE Camden Partners, an independent private equity firm based here, has named former RediClinic executive Christopher Kersey as a partner.

Prior to joining Camden Partners, Kersey served as a managing director of Cogene Ventures, a health care and life science venture capital fund in the South.

Kersey gained operational experience as the chief development officer and chief medical officer of retail clinic operator RediClinic LLC. His clinical research background includes fellowships at the National Institutes of Health (NIH) and the Emory University School of Medicine, where he focused on molecular biology and cardiovascular surgery, respectively.